Table 7. Egg-based QIV brand availability and perceived clinical interchangeability, by country^a.

	Austria	Italy	UK-England
	n (%)	n (%)	n (%)
	(N = 55)	(N = 148)	(N = 12)
I have >1 egg-based QIV brand available for my patients	19 (34.6)	15 (10.1)	1 (8.3)
Perceive egg-based QIV vaccines are clinically interchangeable	(N = 55)	(N = 146)	(N = 12)
Fully	31 (56.4)	55 (37.7)	0 (0)
Mostly	20 (36.4)	65 (44.5)	7 (58.3)
Mostly not	2 (3.6)	15 (10.3)	5 (41.7)
Not at all	2 (3.6)	9 (6.2)	0 (0)

n: number of GPs that chose a particular answer; N: number of GPs that answered the question; QIV: quadrivalent influenza vaccine.

^a This table was not produced for Spain as a single egg-based QIV brand was available in the Valencia region in 2019/2020.